Actividad Investigadora
JA PCM - Joint Action Personalised Cancer Medicine
Datos básicos
Objetivos del proyecto
Personalised cancer medicine (PCM) using personal medical history, physiological status, genomic profiling combined with technologies like imaging are key in cancer management, from prevention to end-of-life care, and in some cases already a standard practice. The key aim of this Joint Action (JA) is to extend access to and knowledge of PCM across Europe with the vision to develop healthcare interventions along the individual’s lifecourse taking a multi-perspective point of view from the healthy person, cancer patient and survivor. The JA partners recognize that prevention, diagnosis, treatment, and follow-up should be approached in a concerted way for optimal patient benefit.
Documentos
- No hay documentos
Participantes
Unidades de investigación
Financiadores
